...
首页> 外文期刊>Therapeutic Drug Monitoring >Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases.
【24h】

Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases.

机译:过量服用喹硫平:14例临床和药代动力学分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Data on quetiapine overdosage are only sparsely available in the literature. This study provides additional data on the pharmacokinetics and clinical effects of intoxication with this atypical antipsychotic drug. The authors performed a retrospective analysis of all quetiapine intoxications reported to and screened by the toxicological laboratory of the Central Hospital Pharmacy The Hague between January 1999 and December 2003. Cases with known suggested amount of intake and medical outcome were included. From the patient's medical record and from the toxicological laboratory findings, patient demographic characteristics (gender, age), details of quetiapine intoxication (estimated time of ingestion, estimated amount of ingestion, and coingested drugs) and clinical parameters were obtained. Severity of intoxication was graded by the Poisoning Severity Score (PSS). Individual pharmacokinetic parameter values were calculated using a one-compartment open model and a Bayesian fitting procedure. Out of a total of 21 intoxications with quetiapine, 14 fulfilled the inclusion criteria. The ingested dose ranged from 1200 to 18,000 mg. The blood concentration ranged from 1.1 to 8.8 mg/L with a lag time of 1 to 26.2 hours between time of ingestion and blood sampling at the emergency ward. The most frequent findings were somnolence and tachycardia. The PSS was minor in 6 patients (43%), moderate in 5 patients (36%), and severe in 3 patients (21%). Severity of intoxication was not associated with a higher amount of quetiapine intake. The authors found no correlation between the serum concentration of quetiapine and the amount ingested. Elimination t(1/2) was not prolonged. It can be concluded that quetiapine intoxications appear to proceed mildly. Tachycardia and somnolence were the main clinical symptoms in our case series. No fatalities occurred. The severity of clinical symptoms was not associated with either a high serum concentration or the suggested amount ingested of quetiapine.
机译:关于喹硫平过量的数据在文献中很少可得。这项研究提供了有关这种非典型抗精神病药中毒的药代动力学和临床效果的其他数据。作者对1999年1月至2003年12月在海牙中央医院药房的毒理学实验室报告并筛选的所有喹硫平中毒进行了回顾性分析。其中包括已知建议摄入量和医疗结局的病例。从患者的病历和毒理学实验室的发现,获得患者的人口统计学特征(性别,年龄),喹硫平中毒的详细信息(估计的摄入时间,估计的摄入量和共同摄入的药物)和临床参数。中毒的严重程度通过中毒严重程度评分(PSS)进行分级。使用一室开放模型和贝叶斯拟合程序计算各个药代动力学参数值。在总共21次喹硫平中毒中,有14次符合纳入标准。摄入剂量为1200至18,000 mg。血液浓度从1.1到8.8 mg / L不等,在急诊病房进食和采样之间有1-2 6.2个小时的滞后时间。最常见的发现是嗜睡和心动过速。 PSS轻微的6例(43%),中度的5例(36%),严重的3例(21%)。中毒的严重程度与喹硫平的摄入量较高无关。作者发现喹硫平的血清浓度与摄入量之间没有相关性。消除时间t(​​1/2)未延长。可以得出结论,喹硫平中毒似乎是轻度进行的。心动过速和嗜睡是本病例系列的主要临床症状。没有发生死亡事故。临床症状的严重程度与高血药浓度或喹硫平的建议摄入量无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号